| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,487 |
5,903 |
$783K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,855 |
3,356 |
$422K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,415 |
695 |
$340K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,791 |
494 |
$224K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,416 |
1,212 |
$123K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,604 |
484 |
$80K |
| 36415 |
Collection of venous blood by venipuncture |
2,393 |
2,038 |
$63K |
| 80053 |
Comprehensive metabolic panel |
4,123 |
3,502 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,492 |
1,440 |
$48K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
443 |
409 |
$34K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,416 |
1,349 |
$32K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,556 |
1,306 |
$31K |
| 70450 |
Computed tomography, head or brain; without contrast material |
163 |
137 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,318 |
3,593 |
$21K |
| 71046 |
Radiologic examination, chest; 2 views |
533 |
490 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,124 |
961 |
$18K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
79 |
67 |
$18K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
137 |
131 |
$17K |
| 81003 |
|
978 |
848 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
205 |
199 |
$14K |
| 81001 |
|
906 |
781 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
563 |
544 |
$12K |
| 71045 |
Radiologic examination, chest; single view |
1,292 |
1,148 |
$11K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
323 |
275 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
61 |
56 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
622 |
480 |
$7K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
150 |
143 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
22 |
17 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
763 |
648 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
36 |
35 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
375 |
321 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
764 |
658 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
347 |
321 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
117 |
103 |
$3K |
| 84703 |
|
691 |
631 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
110 |
89 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
767 |
685 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
574 |
491 |
$2K |
| 87634 |
|
258 |
254 |
$2K |
| 80061 |
Lipid panel |
878 |
797 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
414 |
343 |
$2K |
| 85610 |
|
185 |
96 |
$2K |
| 84484 |
|
380 |
312 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
723 |
637 |
$1K |
| 83690 |
|
392 |
352 |
$815.67 |
| 85027 |
|
124 |
111 |
$568.15 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
216 |
189 |
$502.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
43 |
39 |
$465.74 |
| 82607 |
|
82 |
78 |
$385.77 |
| 84439 |
|
15 |
13 |
$307.69 |
| 87077 |
|
111 |
90 |
$280.13 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
81 |
42 |
$278.28 |
| A9270 |
Non-covered item or service |
100 |
52 |
$259.43 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12 |
12 |
$220.38 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
12 |
$8.06 |
| 83735 |
|
57 |
39 |
$7.38 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
13 |
12 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
39 |
36 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
29 |
26 |
$0.00 |